Junshi Biosciences seeks $500m Hong Kong IPO
Shanghai Junshi Biosciences is eyeing a $500m IPO in Hong Kong, having filed a draft prospectus with the city’s stock exchange.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: